泰拉生物科学

最新新闻

• Tyra Biosciences Price Target Cut to $29.00/Share From $30.00 by HC Wainwright & Co.
  Dow Jones · 2026/9/22
• 公司公告
  TYRA BIOSCIENCES, INC. | SCHEDULE 13G: Others
  SEC · 2026/9/22
• 评级变动
  A Quick Look at Today's Ratings for TYRA BIOSCIENCES, INC.(TYRA.US), With a Forecast Between $39 to $56
  \u5e02\u573a\u8d44\u8baf · 2026/9/8
• 评级变动
  Jefferies Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $42
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• CCORF Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $50
  \u5e02\u573a\u8d44\u8baf · 2026/9/22
• 评级变动
  H.C. Wainwright Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/9/4
• 评级变动
  BofA Securities Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Cuts Target Price to $39
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  JonesTrading Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $56
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 公司公告
  TYRA BIOSCIENCES, INC. | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
  SEC · 2026/9/18
• Oppenheimer Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Cuts Target Price to $40
  \u5e02\u573a\u8d44\u8baf · 2026/9/22
• Barclays Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $59
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 公司公告
  TYRA BIOSCIENCES, INC. | 4: Statement of changes in beneficial ownership of securities-Officer Rueb Yuliya
  SEC · 2026/9/18
• 评级变动
  A Quick Look at Today's Ratings for TYRA BIOSCIENCES, INC.(TYRA.US), With a Forecast Between $30 to $59
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 公司公告
  TYRA BIOSCIENCES, INC. | 4: Statement of changes in beneficial ownership of securities-Officer Harris Todd
  SEC · 2026/9/18
• 评级变动
  Wedbush Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $53
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 公司公告
  TYRA BIOSCIENCES, INC. | 4: Statement of changes in beneficial ownership of securities-Officer Fuhrman Alan
  SEC · 2026/9/18
• 评级变动
  HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $30
  Benzinga · 2026/9/10
• HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $29
  Benzinga · 2026/9/22
• 评级变动
  H.C. Wainwright Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Cuts Target Price to $29
  \u5e02\u573a\u8d44\u8baf · 2026/9/22
• 评级变动
  Raymond James Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Announces Target Price $50
  \u5e02\u573a\u8d44\u8baf · 2026/9/24

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。